Skip to content

To compare buccal versus vaginal route of misoprostol for induction of labor.

A comparative study of buccal versus vaginal misoprostol for induction of labor.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/05/033658
Enrollment
210
Registered
2021-05-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O80- Encounter for full-term uncomplicated delivery

Interventions

Intervention1: Buccal misoprostol: Administration of buccal misoprostol for induction of labor to study the maternal and fetal outcome, drug efficacy and patient acceptability and to compare the same

Sponsors

Department of Obstetrics and Gynaecology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All women with a specific indication for induction of labor, >34 weeks of gestation with an unfavorable cervix and reassuring fetal heart rate.

Exclusion criteria

Exclusion criteria: Women with multiple gestations, Malpresentation, Nonreactive fetal cardiac activity, Previous uterine surgeries, Cephalopelvic Disproportion, Placenta previa, Women with renal, or cardiovascular disease, severe asthma, glaucoma, Known hypersensitivity to prostaglandins, Parity 5 or more

Design outcomes

Primary

MeasureTime frame
To compare the maternal and fetal outcome and drug efficacy between buccal and vaginal route of misoprostol administration in induction of labor.Timepoint: Baseline,4,8,12,16,20,24hours

Secondary

MeasureTime frame
To assess the patient acceptability for each method.Timepoint: Using a questionnaire after the delivery process

Countries

India

Contacts

Public ContactDr Navneet Takkar

Government Medical College Hospital Chandigarh

navneettakkar2015@gmail.com9646121582

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026